§13815. Authorization
1.
Rules for dispensing naloxone hydrochloride.
[PL 2017, c. 364, §6 (RP).]
2.
Rules for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication.
The board by rule shall establish standards for authorizing pharmacists to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A‑1 and C‑1. The rules must establish adequate training requirements and protocols for prescribing and dispensing naloxone hydrochloride or another opioid overdose-reversing medication when there is no prescription drug order, standing order or collaborative practice agreement authorizing naloxone hydrochloride or another opioid overdose-reversing medication to be dispensed to the intended recipient. Rules adopted under this subsection are routine technical rules as defined in Title 5, chapter 375, subchapter 2‑A. A pharmacist authorized by the board pursuant to this subsection to prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication may prescribe and dispense naloxone hydrochloride or another opioid overdose-reversing medication in accordance with Title 22, section 2353, subsection 2, paragraphs A‑1 and C‑1. An opioid overdose-reversing medication referenced in this subsection must be approved by the federal Food and Drug Administration.
SECTION HISTORY
PL 2015, c. 508, §5 (NEW). PL 2017, c. 249, §2 (RPR). PL 2017, c. 364, §§6, 7 (AMD). PL 2023, c. 161, §8 (AMD).